Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
HIV Infection: early-phase trial registry
9 of 74 indexed HIV Infection trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #183 of 28,707 conditions by registered trial count.
74 US clinical trials · 9 currently recruiting · #183 of 28,707 conditions by registered trial count
HIV Infection: 74 US clinical trials tracked, 9 recruiting.
HIV Infection is the subject of 74 registered US clinical trials on ClinicalTrials.gov, 9 of them currently open to new participants. 15 are in Phase 3-4 (later-stage) and 32 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Allergy and Infectious Diseases (NIAID), running 12 of these trials.
Enrollment posture brief
Registry condition hiv-infection
OPEN 9 | RECR 12% | LATE 15 | EARLY 32 | RANK #183 | SPON 12
Volume-matched condition peers
Nearest open-share peer: Hepatitis C (12% recruiting · 108 trials)
HIV Infection lists 9 open slots (12% of 74 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for HIV Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
HIV Infection is recruiting below its size-band peers.
9 of 74 indexed trials (12.2%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates HIV Infection research.
National Institute of Allergy and Infectious Diseases (NIAID) accounts for 12 of 74 trials (16.2%). 40 distinct sponsors appear on at least one study for this condition label.
-
Most HIV Infection trials plan to enrol fewer than 100 people.
Median target enrolment is 55 among the 74 trials that report a genuine target (sentinel values excluded). 48 of those (64.9%) plan for fewer than 100 participants.
-
HIV Infection research is mostly interventional.
57 interventional and 17 observational studies make up this index (77% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
74 total, page 2 of 2
Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00001644
A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1
AbbVie
NCT04223804
The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART
AIM ImmunoTech
NCT00035893
Immune and Viral Status of HIV-Infected Patients After Stopping Combination Antiretroviral Therapy
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00001899
Evaluation of Barriers to Postpartum Care in HIV Infected Women
The University of Texas Health Science Center, Houston
NCT01853917
Cabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus
National Cancer Institute (NCI)
NCT01822522
Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects
Felizarta, Franco, M.D.
NCT01010399
Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract
University of Colorado, Denver
NCT01456962
Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00001474
Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection
National Cancer Institute (NCI)
NCT00001386
Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIV
Massachusetts General Hospital
NCT01407237
Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults
National Institute of Allergy and Infectious Diseases (NIAID)
NCT01993706
Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir
Robert L. Murphy
NCT00976404
Androgen Effects in HIV-infected Women
Massachusetts General Hospital
NCT00095212
Continued Antiretroviral Therapy With Abacavir, Amprenavir and Efavirenz
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00001758
Technology-based Training Tool for PHAT Life
Oregon Research Behavioral Intervention Strategies
NCT05339412
Pharmacokinetics of Antiretroviral Agents in HIV-1 Infected Pregnant Women
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00006320
The Effect of Milk Thistle on the Pharmacokinetics of Indinavir
National Institutes of Health Clinical Center (CC)
NCT00011635
Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Sangamo Therapeutics
NCT01044654
Evaluation of the Safety of a Polyvalent Virus in Healthy Adults
St. Jude Children's Research Hospital
NCT00187044
Reducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral Therapy
Massachusetts General Hospital
NCT02471430
SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial Function
Northwestern University
NCT00225082
Immune Activation and Drug Absorption in HIV-Infected Patients
Drexel University
NCT01845298
IMPAACT P1107: Effects of Cord Blood Transplantation With CCR5Δ32 Donor Cells on HIV Persistence
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
NCT02140944
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 20 |
| Phase 2 | 12 |
| Phase 3 | 8 |
| Phase 4 | 7 |
Top Sponsors
Named interventions
Most-linked intervention names on HIV Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on HIV Infection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this HIV Infection page
74 registered trials, 9 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 9 HIV Infection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Institute of Allergy and Infectious Diseases (NIAID) sponsors the most HIV Infection trials on record, review their full trial history before evaluating a specific study. See National Institute of Allergy and Infectious Diseases (NIAID)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This HIV Infection condition card totals 74 registered trials; most-linked intervention Laboratory Biomarker Analysis; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.